Cargando…

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

BACKGROUND AND AIMS: Recent studies have indicated that circulating miRNAs could serve as accurate biomarkers for diagnosing nonalcoholic fatty liver disease (NAFLD). We aimed to assess the evidence on the probability of circulating miRNAs as new diagnostic biomarkers in patients with NAFLD. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Changzhou, Lin, Yiming, Yu, Chaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720843/ https://www.ncbi.nlm.nih.gov/pubmed/31531307 http://dx.doi.org/10.1155/2019/2096161

Ejemplares similares

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Cai, Changzhou, et al.
Publicado: (2019)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Circulating miRNAs as diagnostic biomarkers for adolescent idiopathic scoliosis
por: García-Giménez, José Luis, et al.
Publicado: (2018)

A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker
por: Ma, Chenkai, et al.
Publicado: (2018)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
por: Lin, Jen-Tai, et al.
Publicado: (2021)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease: Diagnostic biomarkers
por: Hadizadeh, Fatemeh, et al.
Publicado: (2017)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations
por: Xiang, Yunhui, et al.
Publicado: (2021)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
por: Cai, Changzhou, et al.
Publicado: (2021)

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease
por: Cai, Changzhou, et al.
Publicado: (2020)

Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis
por: Cai, Pengfei, et al.
Publicado: (2018)

Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Jin, Xuehang, et al.
Publicado: (2019)

Circulating Exosomal miRNAs as Novel Biomarkers Perform Superior Diagnostic Efficiency Compared With Plasma miRNAs for Large-Artery Atherosclerosis Stroke
por: Niu, Mengying, et al.
Publicado: (2021)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis
por: Zhang, Xiaoyi, et al.
Publicado: (2018)

Diagnostic significance of circulating miRNAs in systemic lupus erythematosus
por: Zheng, Xiaolan, et al.
Publicado: (2019)

Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
por: Panio, A., et al.
Publicado: (2022)

Potential diagnostic role of circulating MiRNAs in colorectal cancer
por: Abo-elela, Dina A, et al.
Publicado: (2023)

Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
por: Ding, Yan, et al.
Publicado: (2017)

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
por: Ragab, Halla M., et al.
Publicado: (2023)

Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients
por: Keramati, Farid, et al.
Publicado: (2021)

miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma
por: Jiang, Li, et al.
Publicado: (2021)

Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
por: Mencias, Mark, et al.
Publicado: (2021)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
por: Tan, Ineke L., et al.
Publicado: (2021)

Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
por: Prajzlerová, Klára, et al.
Publicado: (2022)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
por: Khalifa, Olfa, et al.
Publicado: (2020)

Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia
por: Kim, Suji, et al.
Publicado: (2020)

Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study
por: Zhang, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bkbt8mrtqtn130oqg7hui6n8nh